Annual CFO
-$13.44 M
+$6.01 M+30.92%
December 31, 2023
Summary
- As of February 20, 2025, WINT annual cash flow from operations is -$13.44 million, with the most recent change of +$6.01 million (+30.92%) on December 31, 2023.
- During the last 3 years, WINT annual CFO has risen by +$11.88 million (+46.92%).
- WINT annual CFO is now -140.00% below its all-time high of $33.59 million, reached on December 31, 2016.
Performance
WINT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$6.44 M
-$4.12 M-177.04%
September 30, 2024
Summary
- As of February 20, 2025, WINT quarterly cash flow from operations is -$6.44 million, with the most recent change of -$4.12 million (-177.04%) on September 30, 2024.
- Over the past year, WINT quarterly CFO has stayed the same.
- WINT quarterly CFO is now -110.70% below its all-time high of $60.23 million, reached on December 31, 2016.
Performance
WINT Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$15.28 M
-$2.59 M-20.40%
September 30, 2024
Summary
- As of February 20, 2025, WINT TTM cash flow from operations is -$15.28 million, with the most recent change of -$2.59 million (-20.40%) on September 30, 2024.
- Over the past year, WINT TTM CFO has stayed the same.
- WINT TTM CFO is now -134.74% below its all-time high of $44.00 million, reached on September 30, 2017.
Performance
WINT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
WINT Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +30.9% | 0.0% | 0.0% |
| 3 y3 years | +46.9% | -155.8% | -0.2% |
| 5 y5 years | +14.8% | -155.8% | -0.2% |
WINT Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +43.2% | -177.0% | +4.0% | -20.4% | +37.2% |
| 5 y | 5-year | at high | +46.9% | -177.0% | +21.9% | -20.4% | +41.8% |
| alltime | all time | -140.0% | +76.7% | -110.7% | +77.0% | -134.7% | +76.0% |
Windtree Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.44 M(+177.0%) | -$15.28 M(+20.4%) |
| Jun 2024 | - | -$2.33 M(-21.1%) | -$12.69 M(-8.4%) |
| Mar 2024 | - | -$2.95 M(-17.4%) | -$13.87 M(+3.2%) |
| Dec 2023 | -$13.44 M(-30.9%) | -$3.57 M(-7.4%) | -$13.44 M(+1.4%) |
| Sep 2023 | - | -$3.85 M(+10.2%) | -$13.25 M(-1.8%) |
| Jun 2023 | - | -$3.50 M(+38.8%) | -$13.49 M(-11.5%) |
| Mar 2023 | - | -$2.52 M(-25.5%) | -$15.26 M(-21.6%) |
| Dec 2022 | -$19.45 M(-17.8%) | -$3.38 M(-17.5%) | -$19.45 M(-7.4%) |
| Sep 2022 | - | -$4.10 M(-22.0%) | -$21.00 M(-5.3%) |
| Jun 2022 | - | -$5.26 M(-21.7%) | -$22.19 M(-8.8%) |
| Mar 2022 | - | -$6.71 M(+36.2%) | -$24.33 M(+2.8%) |
| Dec 2021 | -$23.66 M(-6.5%) | -$4.93 M(-6.6%) | -$23.66 M(+1.7%) |
| Sep 2021 | - | -$5.28 M(-28.7%) | -$23.27 M(-11.3%) |
| Jun 2021 | - | -$7.40 M(+22.4%) | -$26.25 M(+1.4%) |
| Mar 2021 | - | -$6.05 M(+33.2%) | -$25.88 M(+2.2%) |
| Dec 2020 | -$25.32 M(+2.6%) | -$4.54 M(-45.0%) | -$25.32 M(-3.5%) |
| Sep 2020 | - | -$8.26 M(+17.3%) | -$26.23 M(+20.3%) |
| Jun 2020 | - | -$7.04 M(+28.4%) | -$21.80 M(+1.9%) |
| Mar 2020 | - | -$5.48 M(+0.4%) | -$21.39 M(-13.3%) |
| Dec 2019 | -$24.66 M(+56.3%) | -$5.46 M(+42.8%) | -$24.66 M(-2.9%) |
| Sep 2019 | - | -$3.82 M(-42.2%) | -$25.39 M(+2.2%) |
| Jun 2019 | - | -$6.62 M(-24.4%) | -$24.85 M(+13.0%) |
| Mar 2019 | - | -$8.76 M(+41.5%) | -$21.99 M(+39.4%) |
| Dec 2018 | -$15.78 M(-25.0%) | -$6.19 M(+88.9%) | -$15.78 M(+9.6%) |
| Sep 2018 | - | -$3.28 M(-13.0%) | -$14.40 M(-0.7%) |
| Jun 2018 | - | -$3.77 M(+47.9%) | -$14.50 M(-10.8%) |
| Mar 2018 | - | -$2.55 M(-47.0%) | -$16.26 M(-22.7%) |
| Dec 2017 | -$21.05 M(-162.7%) | -$4.81 M(+42.4%) | -$21.05 M(-147.8%) |
| Sep 2017 | - | -$3.38 M(-38.9%) | $44.00 M(+12.7%) |
| Jun 2017 | - | -$5.53 M(-24.6%) | $39.04 M(+10.2%) |
| Mar 2017 | - | -$7.33 M(-112.2%) | $35.44 M(+5.5%) |
| Dec 2016 | $33.59 M(-200.3%) | $60.23 M(-822.9%) | $33.59 M(-198.0%) |
| Sep 2016 | - | -$8.33 M(-8.7%) | -$34.29 M(+2.4%) |
| Jun 2016 | - | -$9.13 M(-0.6%) | -$33.48 M(-1.6%) |
| Mar 2016 | - | -$9.19 M(+20.1%) | -$34.03 M(+1.6%) |
| Dec 2015 | -$33.50 M(-18.6%) | -$7.65 M(+1.6%) | -$33.50 M(-6.8%) |
| Sep 2015 | - | -$7.52 M(-22.3%) | -$35.94 M(-8.4%) |
| Jun 2015 | - | -$9.68 M(+11.7%) | -$39.25 M(-0.8%) |
| Mar 2015 | - | -$8.66 M(-14.1%) | -$39.55 M(-3.9%) |
| Dec 2014 | -$41.17 M(+1.8%) | -$10.08 M(-6.9%) | -$41.17 M(+0.1%) |
| Sep 2014 | - | -$10.83 M(+8.5%) | -$41.12 M(+2.1%) |
| Jun 2014 | - | -$9.98 M(-2.9%) | -$40.27 M(-0.6%) |
| Mar 2014 | - | -$10.28 M(+2.4%) | -$40.50 M(+0.1%) |
| Dec 2013 | -$40.45 M(+23.0%) | -$10.03 M(+0.6%) | -$40.45 M(+2.5%) |
| Sep 2013 | - | -$9.98 M(-2.3%) | -$39.48 M(+0.3%) |
| Jun 2013 | - | -$10.21 M(-0.3%) | -$39.36 M(+4.7%) |
| Mar 2013 | - | -$10.23 M(+12.9%) | -$37.57 M(+14.3%) |
| Dec 2012 | -$32.88 M(+44.9%) | -$9.06 M(-8.0%) | -$32.88 M(+12.1%) |
| Sep 2012 | - | -$9.85 M(+16.9%) | -$29.34 M(+15.0%) |
| Jun 2012 | - | -$8.42 M(+51.9%) | -$25.53 M(+10.1%) |
| Mar 2012 | - | -$5.55 M(+0.4%) | -$23.18 M(+2.1%) |
| Dec 2011 | -$22.70 M(-6.5%) | -$5.52 M(-8.4%) | -$22.70 M(-0.4%) |
| Sep 2011 | - | -$6.03 M(-0.7%) | -$22.78 M(+5.0%) |
| Jun 2011 | - | -$6.07 M(+19.8%) | -$21.69 M(-5.4%) |
| Mar 2011 | - | -$5.07 M(-9.6%) | -$22.94 M(-5.5%) |
| Dec 2010 | -$24.27 M(-11.5%) | -$5.61 M(+13.4%) | -$24.27 M(-1.5%) |
| Sep 2010 | - | -$4.95 M(-32.5%) | -$24.64 M(-6.4%) |
| Jun 2010 | - | -$7.32 M(+14.4%) | -$26.31 M(+0.1%) |
| Mar 2010 | - | -$6.40 M(+7.0%) | -$26.30 M(-4.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | -$27.41 M(-13.7%) | -$5.98 M(-9.6%) | -$27.41 M(-6.5%) |
| Sep 2009 | - | -$6.62 M(-9.4%) | -$29.32 M(+2.5%) |
| Jun 2009 | - | -$7.30 M(-2.9%) | -$28.60 M(+1.0%) |
| Mar 2009 | - | -$7.52 M(-4.6%) | -$28.31 M(-10.9%) |
| Dec 2008 | -$31.75 M(+8.0%) | -$7.88 M(+33.7%) | -$31.75 M(-0.9%) |
| Sep 2008 | - | -$5.89 M(-15.9%) | -$32.05 M(-2.0%) |
| Jun 2008 | - | -$7.01 M(-36.1%) | -$32.71 M(-0.5%) |
| Mar 2008 | - | -$10.96 M(+33.9%) | -$32.87 M(+11.8%) |
| Dec 2007 | -$29.39 M(-26.2%) | -$8.19 M(+25.0%) | -$29.39 M(+4.5%) |
| Sep 2007 | - | -$6.55 M(-8.7%) | -$28.12 M(-1.4%) |
| Jun 2007 | - | -$7.17 M(-4.3%) | -$28.52 M(-16.4%) |
| Mar 2007 | - | -$7.49 M(+8.4%) | -$34.13 M(-14.3%) |
| Dec 2006 | -$39.83 M(-30.9%) | -$6.91 M(-0.6%) | -$39.83 M(-34.6%) |
| Sep 2006 | - | -$6.95 M(-45.6%) | -$60.88 M(-4.5%) |
| Jun 2006 | - | -$12.78 M(-3.1%) | -$63.76 M(+6.3%) |
| Mar 2006 | - | -$13.19 M(-52.8%) | -$60.00 M(+4.0%) |
| Dec 2005 | -$57.66 M(+73.0%) | -$27.96 M(+184.3%) | -$57.66 M(+56.2%) |
| Sep 2005 | - | -$9.84 M(+9.1%) | -$36.92 M(+3.3%) |
| Jun 2005 | - | -$9.01 M(-17.0%) | -$35.75 M(+0.3%) |
| Mar 2005 | - | -$10.86 M(+50.5%) | -$35.63 M(+6.9%) |
| Dec 2004 | -$33.34 M(+42.1%) | -$7.22 M(-16.7%) | -$33.34 M(-1.6%) |
| Sep 2004 | - | -$8.66 M(-2.6%) | -$33.89 M(+9.3%) |
| Jun 2004 | - | -$8.89 M(+3.8%) | -$31.02 M(+14.8%) |
| Mar 2004 | - | -$8.57 M(+10.3%) | -$27.01 M(+15.1%) |
| Dec 2003 | -$23.46 M(+71.9%) | -$7.77 M(+34.2%) | -$23.46 M(+19.3%) |
| Sep 2003 | - | -$5.79 M(+18.5%) | -$19.66 M(+10.3%) |
| Jun 2003 | - | -$4.88 M(-2.8%) | -$17.82 M(+4.2%) |
| Mar 2003 | - | -$5.02 M(+26.5%) | -$17.10 M(+25.3%) |
| Dec 2002 | -$13.65 M(+7.9%) | -$3.97 M(+0.6%) | -$13.65 M(-0.6%) |
| Sep 2002 | - | -$3.94 M(-5.2%) | -$13.73 M(+10.0%) |
| Jun 2002 | - | -$4.16 M(+164.8%) | -$12.48 M(+11.8%) |
| Mar 2002 | - | -$1.57 M(-61.2%) | -$11.16 M(-11.7%) |
| Dec 2001 | -$12.64 M(+115.9%) | -$4.05 M(+50.2%) | -$12.64 M(+25.7%) |
| Sep 2001 | - | -$2.70 M(-5.0%) | -$10.06 M(+14.0%) |
| Jun 2001 | - | -$2.84 M(-7.1%) | -$8.83 M(+14.4%) |
| Mar 2001 | - | -$3.06 M(+108.6%) | -$7.71 M(+31.7%) |
| Dec 2000 | -$5.86 M(+41.6%) | -$1.47 M(0.0%) | -$5.86 M(+29.3%) |
| Sep 2000 | - | -$1.47 M(-15.3%) | -$4.53 M(+6.2%) |
| Jun 2000 | - | -$1.73 M(+44.4%) | -$4.26 M(+14.2%) |
| Mar 2000 | - | -$1.20 M(+773.7%) | -$3.73 M(-9.7%) |
| Dec 1999 | -$4.14 M(-39.2%) | -$137.00 K(-88.6%) | -$4.14 M(-23.4%) |
| Sep 1999 | - | -$1.20 M(0.0%) | -$5.40 M(-1.8%) |
| Jun 1999 | - | -$1.20 M(-25.0%) | -$5.50 M(-15.4%) |
| Mar 1999 | - | -$1.60 M(+14.3%) | -$6.50 M(-4.4%) |
| Dec 1998 | -$6.80 M(+36.0%) | -$1.40 M(+7.7%) | -$6.80 M(-21.8%) |
| Sep 1998 | - | -$1.30 M(-40.9%) | -$8.70 M(+31.8%) |
| Jun 1998 | - | -$2.20 M(+15.8%) | -$6.60 M(+4.8%) |
| Mar 1998 | - | -$1.90 M(-42.4%) | -$6.30 M(+26.0%) |
| Dec 1997 | -$5.00 M(+138.1%) | -$3.30 M(-512.5%) | -$5.00 M(+108.3%) |
| Sep 1997 | - | $800.00 K(-142.1%) | -$2.40 M(-36.8%) |
| Jun 1997 | - | -$1.90 M(+216.7%) | -$3.80 M(+58.3%) |
| Mar 1997 | - | -$600.00 K(-14.3%) | -$2.40 M(+14.3%) |
| Dec 1996 | -$2.10 M(-16.0%) | -$700.00 K(+16.7%) | -$2.10 M(+50.0%) |
| Sep 1996 | - | -$600.00 K(+20.0%) | -$1.40 M(+75.0%) |
| Jun 1996 | - | -$500.00 K(+66.7%) | -$800.00 K(-33.3%) |
| Mar 1996 | - | -$300.00 K(-66.7%) | -$1.20 M(0.0%) |
| Dec 1995 | -$2.50 M | - | - |
| Jun 1995 | - | -$900.00 K(+200.0%) | -$1.20 M(+300.0%) |
| Mar 1995 | - | -$300.00 K | -$300.00 K |
FAQ
- What is Windtree Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Windtree Therapeutics?
- What is Windtree Therapeutics annual CFO year-on-year change?
- What is Windtree Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Windtree Therapeutics?
- What is Windtree Therapeutics quarterly CFO year-on-year change?
- What is Windtree Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Windtree Therapeutics?
- What is Windtree Therapeutics TTM CFO year-on-year change?
What is Windtree Therapeutics annual cash flow from operations?
The current annual CFO of WINT is -$13.44 M
What is the all time high annual CFO for Windtree Therapeutics?
Windtree Therapeutics all-time high annual cash flow from operations is $33.59 M
What is Windtree Therapeutics annual CFO year-on-year change?
Over the past year, WINT annual cash flow from operations has changed by +$6.01 M (+30.92%)
What is Windtree Therapeutics quarterly cash flow from operations?
The current quarterly CFO of WINT is -$6.44 M
What is the all time high quarterly CFO for Windtree Therapeutics?
Windtree Therapeutics all-time high quarterly cash flow from operations is $60.23 M
What is Windtree Therapeutics quarterly CFO year-on-year change?
Over the past year, WINT quarterly cash flow from operations has changed by $0.00 (0.00%)
What is Windtree Therapeutics TTM cash flow from operations?
The current TTM CFO of WINT is -$15.28 M
What is the all time high TTM CFO for Windtree Therapeutics?
Windtree Therapeutics all-time high TTM cash flow from operations is $44.00 M
What is Windtree Therapeutics TTM CFO year-on-year change?
Over the past year, WINT TTM cash flow from operations has changed by $0.00 (0.00%)